Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |